Ticagrelor: A Reversible P2Y12 Inhibitor in Preventionof Thrombotic Events
Antiplatelet drugs play a crucial role in patients of coronary artery diseases, cerebrovascular diseases, and maintaining the patency of revascularised arteries and stents after coronary angioplasty. Ticagrelor is a new, reversible inhibitor of P2Y12, a purinergic adenosine di phosphate receptor pre...
Main Author: | Uma Advani , Charu Jain , Alka Bansal , Neha Sharma , Kopal Sharma |
---|---|
Format: | Article |
Language: | English |
Published: |
Sonali Sharma on behalf of Rajasthan University of Health Sciences
2023-09-01
|
Series: | RUHS Journal of Health Sciences |
Subjects: | |
Online Access: | https://ruhsjhs.in/articleDetails.php?artid=TVRVeA== |
Similar Items
-
Tirzepatide: Novel Dual Targeted Treatment for Type 2 Diabetes Mellitus in Adults
by: Noopur Verma; Alka Bansal
Published: (2023-07-01) -
A Case Series of Efavirenz Induced Gynaecomastia
by: Charu Jain , Neha Sharma , Uma Advani , Lokendra Sharma , Munesh Kumar , Monica Jain
Published: (2023-08-01) -
Arthrocentesis for Internal Derangement of Temporomandibular Joint: with and without Sodium Hyaluronate
by: Savita Gupta, Amit Kumar Sharma, Jeetendra Purohit, Sugandha Jain; Hirkani Attarde
Published: (2023-10-01) -
Sustainable land management by restoration of short water cycles and preventionof irreversible matter losses from topsoils
by: W. Ripl, et al.
Published: (2009-09-01) -
A Comparative Study of Active and Passive Adverse Drug Reaction Monitoring Methods in Category I Tuberculosis Patients at a Tertiary Care Hospital in India
by: Alka Bansal, et al.
Published: (2020-12-01)